Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Hypertension. 2012 Feb;59(2):283-90. doi: 10.1161/HYPERTENSIONAHA.111.180844. Epub 2011 Dec 27.
-Angiotensin-converting enzyme (ACE) is composed of the N- and C-terminal catalytic domains. To study the role of the ACE domains in the inflammatory response, N-knockout (KO) and C-KO mice, models lacking 1 of the 2 ACE domains, were analyzed during angiotensin II-induced hypertension. At 2 weeks, N-KO mice have systolic blood pressures that averaged 173±4.6 mm Hg, which is more than 25 mm Hg higher than the blood pressures observed in wild-type or C-KO mice (146±3.2 and 147±4.2 mm Hg). After 3 weeks, blood pressure differences between N-KO, C-KO, and wild-type were even more pronounced. Macrophages from N-KO mice have increased expression of tumor necrosis factor α after stimulation with either lipopolysaccharide (about 4-fold) or angiotensin II (about 2-fold), as compared with C-KO or wild-type mice. Inhibition of the enzyme prolyl oligopeptidase, responsible for the formation of acetyl-SerAspLysPro and other peptides, eliminated the blood pressure difference and the difference in tumor necrosis factor α expression between angiotensin II-treated N-KO and wild-type mice. However, this appears independent of acetyl-SerAspLysPro. These data establish significant differences in the inflammatory response as a function of ACE N- or C-domain catalytic activity. They also indicate a novel role of prolyl oligopeptidase in the cytokine regulation and in the blood pressure response to experimental hypertension.
血管紧张素转换酶(ACE)由 N 端和 C 端催化结构域组成。为了研究 ACE 结构域在炎症反应中的作用,分析了缺乏 2 个 ACE 结构域之一的 N 敲除(KO)和 C-KO 小鼠在血管紧张素 II 诱导的高血压期间的情况。在 2 周时,N-KO 小鼠的收缩压平均为 173±4.6mmHg,比野生型或 C-KO 小鼠的血压高 25mmHg 以上(146±3.2 和 147±4.2mmHg)。3 周后,N-KO、C-KO 和野生型之间的血压差异更加明显。与 C-KO 或野生型小鼠相比,N-KO 小鼠的巨噬细胞在受到脂多糖(约 4 倍)或血管紧张素 II(约 2 倍)刺激后,肿瘤坏死因子 α 的表达增加。负责形成乙酰-SerAspLysPro 和其他肽的脯氨酰寡肽酶的抑制作用消除了血管紧张素 II 处理的 N-KO 和野生型小鼠之间的血压差异和肿瘤坏死因子 α 表达的差异。然而,这似乎与乙酰-SerAspLysPro 无关。这些数据确立了 ACE N 或 C 结构域催化活性作为炎症反应功能的显著差异。它们还表明脯氨酰寡肽酶在细胞因子调节和实验性高血压的血压反应中具有新的作用。